Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q3
$150K Sell
3,814
-23,227
-86% -$930K ﹤0.01% 5495
2014
Q2
$1.1M Buy
27,041
+10,664
+65% +$406K ﹤0.01% 3455
2014
Q1
$582K Sell
16,377
-786
-5% -$29.8K ﹤0.01% 4072
2013
Q4
$711K Sell
17,163
-27,866
-62% -$1.18M ﹤0.01% 3928
2013
Q3
$1.93M Sell
45,029
-87,957
-66% -$3.6M ﹤0.01% 2631
2013
Q2
$5.64M Buy
+132,986
New +$5.67M 0.01% 1508

Other funds holding ITRI

UBS's ITRI Position: Q3 2014 in Review

UBS reduced its Itron (ITRI) stake by 86% in Q3 2014, selling an estimated $930K and leaving 3,814 shares worth $150K. The position accounts for ﹤0.01% of the portfolio, ranked #5495.

UBS first reported a position in ITRI in Q2 2013 and has held it in 6 quarters since. The position peaked at $5.64M in Q2 2013. 212 funds tracked by Wall St. Rank hold ITRI as of Q3 2014.

  • UBS held 3,814 shares of Itron worth $150K as of Q3 2014.
  • UBS sold 23,227 Itron shares in Q3 2014, an estimated $930K.
  • Itron made up ﹤0.01% of UBS's portfolio in Q3 2014, its #5495 holding.
  • UBS first reported a position in Itron in Q2 2013 and has held it in 6 quarters since.
  • UBS's Itron position peaked at $5.64M in Q2 2013.
  • 212 funds tracked by Wall St. Rank held Itron as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.